Incretin drugs effect on epigenetic machinery: New potential therapeutic implications in preventing vascular diabetic complications.

Scisciola, Lucia; Rizzo, Maria Rosaria; Cataldo, Vittoria; Fontanella, Rosaria Anna; Balestrieri, Maria Luisa; D'Onofrio, Nunzia; Marfella, Raffaele; Paolisso, Giuseppe; Barbieri, Michelangela

Scisciola, Lucia; Rizzo, Maria Rosaria; Cataldo, Vittoria; Fontanella, Rosaria Anna; Balestrieri, Maria Luisa; D'Onofrio, Nunzia; Marfella, Raffaele; Paolisso, Giuseppe; Barbieri, Michelangela.

Afiliación

Scisciola L; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Rizzo MR; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Cataldo V; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Fontanella RA; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Balestrieri ML; Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
D'Onofrio N; Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Marfella R; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Paolisso G; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Barbieri M; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

FASEB J ; 34(12): 16489-16503, 2020 12.

Article en En | MEDLINE | ID: mdl-33090591

Asunto(s)

Aterosclerosis/prevención & control; Complicaciones de la Diabetes/prevención & control; Diabetes Mellitus Tipo 2/complicaciones; Epigénesis Genética/efectos de los fármacos; Incretinas/farmacología; Aterosclerosis/genética; Glucemia/efectos de los fármacos; Glucemia/genética; Índice de Masa Corporal; Grosor Intima-Media Carotídeo; Línea Celular; Metilación de ADN/efectos de los fármacos; Metilación de ADN/genética; Complicaciones de la Diabetes/genética; Diabetes Mellitus Tipo 2/genética; Diabetes Mellitus Tipo 2/metabolismo; Células Endoteliales/efectos de los fármacos; Epigénesis Genética/genética; Expresión Génica/efectos de los fármacos; Receptor del Péptido 1 Similar al Glucagón/genética; Glucosa/genética; Humanos; FN-kappa B/genética; Superóxido Dismutasa/genética

Palabras clave

DNA methylation; atherosclerosis progression; incretin based drugs; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Epigénesis Genética / Complicaciones de la Diabetes / Diabetes Mellitus Tipo 2 / Aterosclerosis / Incretinas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: FASEB J Asunto de la revista: BIOLOGIA / FISIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google